| Literature DB >> 29348801 |
Abstract
A shocking state of affairs; the use of nanoparticles as simple carriers is dead and outdated. Stimuli-responsive nanoparticles have emerged as active participants in the therapeutic landscape, rather than inert molecule carriers. And this time they are here to join the ongoing war against an old enemy: bacteria.Entities:
Year: 2017 PMID: 29348801 PMCID: PMC5767882 DOI: 10.1021/acsmedchemlett.7b00455
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.345